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The Golgi apparatus consists of disc-like cisternae, stretching around the nucleus through forces
exerted by F-actin and the Golgi membrane protein GOLPH3. Farber-Katz et al. now report that
DNA damage triggers Golgi dispersal and inhibits vesicular transport through DNA-PK-mediated
GOLPH3 phosphorylation, thereby linking the DNA damage response to Golgi regulation.The Golgi apparatus is a eukaryotic
organelle essential for secretion, biogen-
esis and intracellular distribution of a
wide range of macromolecules. Bidirec-
tional membrane trafficking exists be-
tween the Golgi and the endoplasmic
reticulum (ER), which is continuous with
the outer nuclear membrane. The Golgi
ribbon is stretched around the nucleus,
and its characteristic shape is attained
by the tensile forces exerted by F-actin
and GOLPH3, an effector of the phospha-
tidylinositol-4-phosphate (Dippold et al.,
2009). A report in this issue reveals that
Golgi morphology changes dramatically
in response to DNA damage, from the
typical perinuclear ribbon to punctate
fragments dispersed in the cytoplasm
(Farber-Katz et al., 2014). Golgi dispersal
requires GOLPH3 phosphorylation by
DNA-PK, a nuclear protein kinase that is
a crucial component of the DNA damage
response (DDR) (Figure 1). These findings
highlight a link between a key kinase
involved in DDR and important cyto-
plasmic circuits mediating cell trafficking
in mammalian cells.
Intriguingly, earlier genetic screens in
the yeastS. cerevisiae identifiedmutations
in components of the ESCRT complex,
involved in vesicle trafficking, that increase
the levels of DNA topoisomerase Top1
in a SUMO-dependent manner (Reid
et al., 2011). Moreover, mutants of the
retromermembrane coat complex, essen-
tial for endosome-to-Golgi retrograde
protein transport, genetically interact with
YKU70D strains (Addinall et al., 2011)
that lack the gene encoding KU70, a pro-
tein involved in telomere capping and, in
mammals, a key partner of DNA-PK.392 Cell 156, January 30, 2014 ª2014 ElsevieWhile the exact cellular roles of the
Golgi response to DNA damage are not
yet fully elucidated, the findings provide
tantalizing clues. The DNA-PK-mediated
Golgi dispersal persists for weeks after
the exposure to DNA damaging agents,
raising the possibility that it may repre-
sent an adaptive response to genotoxic
insults. The authors thus propose that
Golgi dispersal might alter the trafficking
of key cargoes that influence cell sur-
vival under DNA damaging conditions.
Another possibility is that such altered
trafficking might impact the intracellular
pools or the intracellular localization of
ubiquitin and sumo, thus influencing
the levels or activity of various ubiquity-
lated and sumoylated proteins involved
in the DDR.
Another finding by Farber-Katz et al.
that has the potential for great impact
is that exposure to genotoxic insults
enhances phosphorylation and activity of
GOLPH3, which contributes to cell sur-
vival. Accordingly, GOLPH3 overexpres-
sion also causes Golgi dispersal. Notably,
GOLPH3 qualifies as an oncogene and
is overexpressed and/or amplified in
diverse types of cancer, correlating with
poor prognosis (Scott et al., 2009). Given
that cancer cells feature enhanced
endogenous replication stress and DNA
breakage (Halazonetis et al., 2008), the
observed overabundance of GOLPH3 in
tumors may contribute to their adaptation
and survival under such stressful condi-
tions, as well as under radiotherapy or
chemotherapy. Consequently, the Golgi
dispersal mechanism may have clinical
implications, as it likely supports growth
of highly genetically unstable tumorsr Inc.and enhances the resistance to DNA
damaging treatments used in oncology.
Therefore, GOLPH3 might serve as a
potential prognostic or even predictive
biomarker. Furthermore, considering that
neurodegenerative diseases are often
caused by alterations in the cell-traf-
ficking apparatus and that genetic syn-
dromes caused by mutations in genes
involved in the DDR are commonly
associated with neurodegeneration, it is
tantalizing to speculate that the link be-
tween trafficking and DDR described
by Farber-Katz et al. might inspire future
studies aimed at understanding the con-
nections between cancer and neurode-
generation.
The upstream mechanism leading
to activation and transduction of the
process that ultimately causes Golgi
dispersal and altered cell trafficking in
response to DNA damage is yet to be
determined. DNA double-strand break
recognition can be mediated by the Ku
heterodimer that recruits DNA-PK (Kong
et al., 2011) to promote non-homolo-
gous-end-joining (NHEJ)-mediated DNA
repair. Since the authors find that
GOLPH3, in addition to being directly
phosphorylated by DNA-PK, also binds
to Ku80 and that the DNA damaging
agents used to induce Golgi dispersal
directly or indirectly cause DNA breaks,
it is possible that the process leading
to Golgi dispersal is directly triggered by
the accumulation of damaged DNA. It
would be thus interesting to test whether
other types of DNA damaging agents,
different from ionizing radiation or radio-
mimetic drugs, also promote this pro-
cess. Notably, Golgi dispersal appears
Figure 1. DNA-PK-Mediated Golgi Regula-
tion in Response to DNA Damage
Chromatin is physically connected to the nuclear
envelope, which is continuous with the endo-
plasmic reticulum (ER). Membrane contact sites
connect the ER with the Golgi apparatus and with
the plasma membrane. GOLPH3 (dark blue shape)
is attached to actin (black lines). DNA double-
strand breaks generate a signal (red dot) leading
to GOLPH3 phosphorylation through a pro-
cess (arrow) mediated by DNA-PK, inducing
Golgi dispersal, impaired intracellular trafficking,
and enhanced cell survival. The zoomed-in area
depicts DNA-PK-mediated phosphorylation of the
critical T143/T148 residues of GOLPH3.to be independent of ATR and ATM, two
other key DDR kinases. It also remains
to be elucidated how DNA-PK trans-
duces the signal to a cytoplasmic factor
such as GOLPH3. In fact, DNA-PK has
been implicated in regulating a variety ofcellular pathways, unrelated to DNA
repair and nuclear functions, including
the inflammatory response and meta-
bolic gene regulation (Kong et al., 2011).
Moreover, both DNA-PK and Ku are
also associated with cytoplasmic mem-
branes and lipid rafts, microdomains of
the plasma membrane that mediate
signal transduction events, membrane
fluidity, and protein trafficking (Lucero
et al., 2003), making the scenario of
DNA-PK GOLPH3 activation even more
complex. Furthermore, chromatin is
physically connected with the nuclear
envelope, which is continuous with the
ER, and electron microscopy analysis
has shown that specific membrane
contact sites connect different cellular
organelles, including the ER with the
Golgi apparatus (Elbaz and Schuldiner,
2011), suggesting physical continuity
between the nuclear DNA and the Golgi.
An efficient way of signaling across struc-
tures that are physically connected
by elastic components such as cellular
membranes and the chromatin fibers
is through mechanotransduction (Wang
et al., 2009). The DNA-PK/Ku complex
binds both DNA and membranes, repre-
senting an ideal scaffold to link mechani-
cal forces and catalytic reactions. Hence,
it might be possible that part of the
phenomenon observed by Farber-Katz
et al. is influenced by mechanotrans-
duction events triggered by chromatin
dynamics and involving Golgi shape
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